151 related articles for article (PubMed ID: 8338781)
21. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
Rucińska M; Machaczka M; Załuska A; Skotnicki AB
Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
[TBL] [Abstract][Full Text] [Related]
22. Assessment of bone marrow infiltration by magnetic resonance imaging in patients with hairy cell leukemia treated with pentostatin or alpha-interferon.
Bentz M; Döhner H; Gückel F; Semmler W; Kauczor HU; van Kaick G; Ho AD; Hunstein W
Leukemia; 1991 Oct; 5(10):905-7. PubMed ID: 1961024
[TBL] [Abstract][Full Text] [Related]
23. Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine.
Juliusson G; Lenkei R; Liliemark J
Blood; 1994 Jun; 83(12):3672-81. PubMed ID: 7911341
[TBL] [Abstract][Full Text] [Related]
24. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine.
Jehn U; Bartl R; Dietzfelbinger H; Haferlach T; Heinemann V
Leukemia; 2004 Sep; 18(9):1476-81. PubMed ID: 15229616
[TBL] [Abstract][Full Text] [Related]
25. Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse.
Tallman MS; Hakimian D; Kopecky KJ; Wheaton S; Wollins E; Foucar K; Cassileth PA; Habermann T; Grever M; Rowe JM; Peterson LC
Clin Cancer Res; 1999 Jul; 5(7):1665-70. PubMed ID: 10430066
[TBL] [Abstract][Full Text] [Related]
26. Long term outcome of patients with hairy cell leukemia treated with pentostatin.
Ribeiro P; Bouaffia F; Peaud PY; Blanc M; Salles B; Salles G; Coiffier B
Cancer; 1999 Jan; 85(1):65-71. PubMed ID: 9921975
[TBL] [Abstract][Full Text] [Related]
27. Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia.
Urba WJ; Baseler MW; Kopp WC; Steis RG; Clark JW; Smith JW; Coggin DL; Longo DL
Blood; 1989 Jan; 73(1):38-46. PubMed ID: 2783373
[TBL] [Abstract][Full Text] [Related]
28. [Hairy cell leukemia successfully treated with deoxycoformycin].
Matsuda A; Jinnai I; Mizuno H; Sakata T; Kusumoto S; Kayano H; Takeuchi H; Bessho M; Saito M; Katayama I
Rinsho Ketsueki; 1992 Nov; 33(11):1685-90. PubMed ID: 1469784
[TBL] [Abstract][Full Text] [Related]
29. Sezary syndrome in a patient with hairy cell leukemia in remission.
Crump M; Sutton DM; Pantalony D
Cancer; 1991 Aug; 68(4):829-33. PubMed ID: 1649686
[TBL] [Abstract][Full Text] [Related]
30. Treatment of hairy cell leukemia with deoxycoformycin (YK-176). The Deoxycoformycin (YK-176) Study Group.
Shimoyama M; Tobinai K; Yamaguchi K; Hirashima K; Itoh S; Konishi H; Mikuni C; Togawa A; Hotta T; Toyoda N
Jpn J Clin Oncol; 1992 Dec; 22(6):406-10. PubMed ID: 1291757
[TBL] [Abstract][Full Text] [Related]
31. Deoxycoformycin in the treatment of patients with hairy cell leukemia: results of a Spanish collaborative study of 80 patients.
Rafel M; Cervantes F; Beltrán JM; Zuazu F; Hernández Nieto L; Rayón C; García Talavera J; Montserrat E
Cancer; 2000 Jan; 88(2):352-7. PubMed ID: 10640967
[TBL] [Abstract][Full Text] [Related]
32. Long-term follow-up of patients with hairy cell leukemia after treatment with 2'-deoxycoformycin.
Kraut EH; Grever MR; Bouroncle BA
Blood; 1994 Dec; 84(12):4061-3. PubMed ID: 7994024
[TBL] [Abstract][Full Text] [Related]
33. Hairy cell leukaemia, its therapy and prognosis (historical review with own experiences).
Chrobák L; Podzimek K; Zak P; Plísková L; Voglová J
Acta Haematol Pol; 1995; 26(2 Suppl 1):56-62. PubMed ID: 7653236
[TBL] [Abstract][Full Text] [Related]
34. Advances in therapy for hairy cell leukemia. A review.
Jaiyesimi IA; Kantarjian HM; Estey EH
Cancer; 1993 Jul; 72(1):5-16. PubMed ID: 7685243
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of aplastic variant of hairy-cell leukaemia with deoxycoformycin.
Ng JP; Nolan B; Chan-Lam D; Coup AJ; McKenna D
Hematology; 2002 Aug; 7(4):259-62. PubMed ID: 14972788
[TBL] [Abstract][Full Text] [Related]
36. The treatment of hairy-cell leukaemia with 2'-deoxycoformycin.
Johnston JB; Glazer RI; Pugh L; Israels LG
Br J Haematol; 1986 Jul; 63(3):525-34. PubMed ID: 3488071
[TBL] [Abstract][Full Text] [Related]
37. 2'-Deoxycoformycin (Pentostatin) in hairy cell leukemia: response in patients refractory to interferon alpha.
Ho AD; Kuse R; Prümmer O; Porzsolt F; Hunstein W
Klin Wochenschr; 1987 Oct; 65(20):975-9. PubMed ID: 3501501
[TBL] [Abstract][Full Text] [Related]
38. Persistent bone marrow failure with dysplastic features following pentostatin therapy for hairy cell leukaemia.
Psiachou-Leonard E; Bain BJ
Clin Lab Haematol; 1998 Jun; 20(3):195-7. PubMed ID: 9681239
[TBL] [Abstract][Full Text] [Related]
39. Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine.
Dearden CE; Matutes E; Hilditch BL; Swansbury GJ; Catovsky D
Br J Haematol; 1999 Aug; 106(2):515-9. PubMed ID: 10460614
[TBL] [Abstract][Full Text] [Related]
40. Role of interferon-alpha administration after 2-deoxycoformycin in the treatment of hairy cell leukemia patients.
Marotta G; Frassoldati A; Zinzani P; Annino L; Brugiatelli M; Ambrosetti A; Lenoci M; Federico M; Foa R; Lauria F;
Eur J Haematol; 2006 Aug; 77(2):109-13. PubMed ID: 16856905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
